All Cosmos Bio-Tech Holding Corp
All Cosmos Bio-Tech Holding Corporation, through its subsidiaries, manufactures and sells bio-organic and bio-chemical compound fertilizers in Malaysia and internationally. The company offers bio-chemical fertilizers, as well as offers water reutilization services. It also engages in the research and development of microorganisms for waste disposal of oil-palm; and wholesale of probiotics. In add… Read more
All Cosmos Bio-Tech Holding Corp (4148) - Total Assets
Latest total assets as of September 2025: NT$3.88 Billion TWD
Based on the latest financial reports, All Cosmos Bio-Tech Holding Corp (4148) holds total assets worth NT$3.88 Billion TWD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
All Cosmos Bio-Tech Holding Corp - Total Assets Trend (2010–2024)
This chart illustrates how All Cosmos Bio-Tech Holding Corp’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
All Cosmos Bio-Tech Holding Corp - Asset Composition Analysis
Current Asset Composition (December 2024)
All Cosmos Bio-Tech Holding Corp's total assets of NT$3.88 Billion consist of 72.5% current assets and 27.5% non-current assets.
| Asset Category | Amount (TWD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 25.4% |
| Accounts Receivable | NT$623.08 Million | 17.0% |
| Inventory | NT$675.03 Million | 18.4% |
| Property, Plant & Equipment | NT$0.00 | 0.0% |
| Intangible Assets | NT$11.16 Million | 0.3% |
| Goodwill | NT$383.00K | 0.0% |
Asset Composition Trend (2010–2024)
This chart illustrates how All Cosmos Bio-Tech Holding Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: All Cosmos Bio-Tech Holding Corp's current assets represent 72.5% of total assets in 2024, an increase from 65.6% in 2010.
- Cash Position: Cash and equivalents constituted 25.4% of total assets in 2024, up from 19.0% in 2010.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 15.0% in 2010.
- Asset Diversification: The largest asset category is inventory at 18.4% of total assets.
All Cosmos Bio-Tech Holding Corp Competitors by Total Assets
Key competitors of All Cosmos Bio-Tech Holding Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Nanjing Red Sun Co Ltd
SHE:000525
|
China | CN¥6.84 Billion |
|
ADAMA Ltd
SHE:000553
|
China | CN¥49.93 Billion |
|
Grand Industrial Holding Co Ltd
SHE:000626
|
China | CN¥8.43 Billion |
|
Qinghai Salt Lake Industry Co.Ltd
SHE:000792
|
China | CN¥50.97 Billion |
|
Sichuan Meifeng Chemical Industry Co Ltd
SHE:000731
|
China | CN¥5.17 Billion |
|
Asia Potash International Investment Guangzhou Co Ltd
SHE:000893
|
China | CN¥19.38 Billion |
|
Hubei Xinyangfeng Fertilizer Co Ltd
SHE:000902
|
China | CN¥19.75 Billion |
|
Sichuan Lutianhua Co Ltd
SHE:000912
|
China | CN¥9.46 Billion |
All Cosmos Bio-Tech Holding Corp - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - All Cosmos Bio-Tech Holding Corp generates 0.67x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, All Cosmos Bio-Tech Holding Corp generates $ 3.50 in net profit.
All Cosmos Bio-Tech Holding Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.20 | 5.51 | 8.25 |
| Quick Ratio | 3.75 | 3.93 | 7.01 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | NT$2.24 Billion | NT$ 2.29 Billion | NT$ 1.61 Billion |
All Cosmos Bio-Tech Holding Corp - Advanced Valuation Insights
This section examines the relationship between All Cosmos Bio-Tech Holding Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.01 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | -0.1% |
| Total Assets | NT$3.67 Billion |
| Market Capitalization | $32.62 Million USD |
Valuation Analysis
Below Book Valuation: The market values All Cosmos Bio-Tech Holding Corp's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: All Cosmos Bio-Tech Holding Corp's assets decreased by 0.1% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for All Cosmos Bio-Tech Holding Corp (2010–2024)
The table below shows the annual total assets of All Cosmos Bio-Tech Holding Corp from 2010 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | NT$3.67 Billion | -0.09% |
| 2023-12-31 | NT$3.67 Billion | -10.64% |
| 2022-12-31 | NT$4.11 Billion | +38.43% |
| 2021-12-31 | NT$2.97 Billion | +13.60% |
| 2020-12-31 | NT$2.61 Billion | -0.95% |
| 2019-12-31 | NT$2.64 Billion | -11.27% |
| 2018-12-31 | NT$2.97 Billion | +10.69% |
| 2017-12-31 | NT$2.69 Billion | +27.18% |
| 2016-12-31 | NT$2.11 Billion | -10.08% |
| 2015-12-31 | NT$2.35 Billion | -0.55% |
| 2014-12-31 | NT$2.36 Billion | +21.18% |
| 2013-12-31 | NT$1.95 Billion | +5.92% |
| 2012-12-31 | NT$1.84 Billion | +40.06% |
| 2011-12-31 | NT$1.31 Billion | +32.07% |
| 2010-12-31 | NT$995.12 Million | -- |